Magda Wierzycka is in the C-SUITE

Wierzycka steps down as Co-CEO of Sygnia in a planned move to focus on providing strategic direction for the company from an innovation perspective. Wierzycka and her husband retain majority control of Sygnia and have no intention of reducing their stake as they see Sygnia’s journey has just begun. Magda also provides an update on the hotly debated AstraZeneca Vaccine